• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马用抗寄生虫药物的评估方法

Methods in the evaluation of antiparasitic drugs in the horse.

作者信息

Drudge J H, Lyons E T

出版信息

Am J Vet Res. 1977 Oct;38(10):1581-6.

PMID:337859
Abstract

The critical test is the primary method used for the efficacy evaluation of drugs against the major internal parasites (bots, ascarids, large strongyles, small strongyles, and pinworms) of the horse. The critical test determines: (1) spectrum of activity, (2) effectiveness of removal, (3) pattern of discharge, and (4) physical condition of each species of these parasites. General characteristics of the major parasitisms of the horse are discussed briefly. Criteria of the critical test also are considered including: (1) number of tests, (2) strain variation and drug resistance, (3) selection of test horses, (4) diagnosis of parasitic species, (5) numbers of parasites, (6) minimal efficacy requirements, and (7) other parasitic species. The controlled test principally is used on a selected basis for the small nematodes in the proximal portion of the digestive tract which cannot be properly evaluated by the critical test, or for other limited objectives. Clinical trials are discussed briefly but are invaluable supplements to the critical and controlled tests in the total assessment of a drug as a new product or for continued effectiveness in clinical use. Experimental procedures used in the conduct of drug evaluations should not be rigidly prescribed but should reflect input by the individual investigatior.

摘要

关键试验是用于评估药物对马的主要体内寄生虫(胃蝇蛆、蛔虫、大型圆线虫、小型圆线虫和蛲虫)疗效的主要方法。关键试验可确定:(1)活性谱,(2)清除效果,(3)排出模式,以及(4)这些寄生虫各物种的身体状况。简要讨论了马主要寄生虫病的一般特征。还考虑了关键试验的标准,包括:(1)试验次数,(2)菌株变异和耐药性,(3)试验马的选择,(4)寄生虫物种的诊断,(5)寄生虫数量,(6)最低疗效要求,以及(7)其他寄生虫物种。对照试验主要在选定的基础上用于消化道近端的小型线虫,这些线虫无法通过关键试验进行适当评估,或用于其他有限目的。简要讨论了临床试验,但在全面评估一种药物作为新产品或其临床使用中的持续有效性时,临床试验是对关键试验和对照试验的宝贵补充。进行药物评估所采用的实验程序不应严格规定,而应反映个体研究者的意见。

相似文献

1
Methods in the evaluation of antiparasitic drugs in the horse.马用抗寄生虫药物的评估方法
Am J Vet Res. 1977 Oct;38(10):1581-6.
2
Critical tests of anthelmintic activity of a paste formulation of thiabendazole in horses.噻苯达唑膏剂对马驱虫活性的关键试验
Am J Vet Res. 1976 Jun;37(6):701-2.
3
Critical tests of new benzothiazole anthelmintic tioxidazole in the horse.新型苯并噻唑驱虫药替奥硝唑在马身上的关键试验。
Am J Vet Res. 1980 Sep;41(9):1383-7.
4
Oxibendazole: critical anthelmintic trials in equids.奥苯达唑:马属动物的关键驱虫试验
Vet Rec. 1975 Dec 6;97(23):442-4.
5
Critical and clinical test evaluations of mebendazole against internal parasites of the horse.甲苯咪唑对马体内寄生虫的关键及临床测试评估
Am J Vet Res. 1974 Nov;35(11):1409-12.
6
Critical tests and safety studies on trichlorfon as an antiparasitic agent in the horse.敌百虫作为马匹抗寄生虫剂的关键试验和安全性研究。
Am J Vet Res. 1976 Feb;37(2):139-44.
7
Critical tests of the antiparasitic activity of thiabendazole and trichlorfon sequentially administered to horses via stomach tube.通过胃管依次给马施用噻苯达唑和敌百虫后,对其抗寄生虫活性进行的关键试验。
Am J Vet Res. 1977 Jun;38(6):721-3.
8
Critical tests of oxfendazole against internal parasites of horses.奥芬达唑对马体内寄生虫的关键试验。
Am J Vet Res. 1977 Dec;38(12):2049-53.
9
Critical test evaluations of oxfendazole and trichlorfon: effectiveness of a paste formulation in the horse.奥芬达唑和敌百虫的关键试验评估:一种膏剂配方对马的有效性。
Am J Vet Res. 1984 Jun;45(6):1203-4.
10
Critical test of three salts of pyrantel against internal parasites of the horse.三种噻嘧啶盐对马体内寄生虫的关键试验。
Am J Vet Res. 1974 Dec;35(12):1515-22.

引用本文的文献

1
Equine tapeworm (Anoplocephala spp.) infection: evaluation of saliva- and serum-based antibody detection methods and risk factor analysis in Slovak horse populations.马属带绦虫(Anoplocephala spp.)感染:斯洛伐克马群基于唾液和血清的抗体检测方法评估及风险因素分析。
Parasitol Res. 2023 Dec;122(12):3037-3052. doi: 10.1007/s00436-023-07994-1. Epub 2023 Oct 7.
2
Meta-analysis of cyathostomin species-specific prevalence and relative abundance in domestic horses from 1975-2020: emphasis on geographical region and specimen collection method.1975-2020 年家养马中旋毛虫属物种特异性流行率和相对丰度的荟萃分析:重点关注地理位置和样本采集方法。
Parasit Vectors. 2020 Oct 12;13(1):509. doi: 10.1186/s13071-020-04396-5.
3
Nematode Species Identification-Current Status, Challenges and Future Perspectives for Cyathostomins.
杯环线虫的线虫种类鉴定——现状、挑战与未来展望
Front Cell Infect Microbiol. 2017 Jun 28;7:283. doi: 10.3389/fcimb.2017.00283. eCollection 2017.
4
Further indication of lowered activity of ivermectin on immature small strongyles in the intestinal lumen of horses on a farm in Central Kentucky.进一步表明,在肯塔基州中部一个农场的马的肠道腔中,伊维菌素对未成熟的小肠旋毛线虫的活性降低。
Parasitol Res. 2013 Feb;112(2):889-91. doi: 10.1007/s00436-012-3098-0. Epub 2012 Sep 5.
5
Three recently recognized species of cyathostomes (Nematoda: Strongylidae) in equids in Kentucky.肯塔基州马属动物中三种新近确认的Cyathostominae 线虫(Nematoda:Strongylidae)。
Parasitol Res. 2011 May;108(5):1179-84. doi: 10.1007/s00436-010-2160-z. Epub 2010 Nov 24.
6
Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky.对肯塔基州中部田间试验中活动减少的马群中小型马蛔虫的莫昔克丁疗效进行的关键测试。
Parasitol Res. 2010 Nov;107(6):1495-8. doi: 10.1007/s00436-010-2025-5. Epub 2010 Aug 17.
7
Probable reason why small strongyle EPG counts are returning "early" after ivermectin treatment of horses on a farm in Central Kentucky.肯塔基州中部一个农场的马匹接受伊维菌素治疗后,小型圆线虫每克粪便虫卵计数(EPG)“过早”回升的可能原因。
Parasitol Res. 2009 Feb;104(3):569-74. doi: 10.1007/s00436-008-1231-x. Epub 2008 Oct 18.
8
Population-S benzimidazole- and tetrahydropyrimidine-resistant small strongyles in a pony herd in Kentucky (1977-1999): effects of anthelmintic treatment on the parasites as determined in critical tests.肯塔基州一个小马群中对苯并咪唑和四氢嘧啶耐药的小型圆线虫(1977 - 1999年):在关键试验中确定的驱虫治疗对寄生虫的影响
Parasitol Res. 2003 Nov;91(5):407-11. doi: 10.1007/s00436-003-0983-6. Epub 2003 Oct 7.